Long-Term Liabilities: The sum of all non-current liabilities.
Spruce Biosciences, Inc. (SPRB) had Long-Term Liabilities of $0.50M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.21M |
|
-- |
|
-- |
|
$8.23M |
|
$-8.23M |
|
$0.02M |
|
$-8.21M |
|
$-8.21M |
|
$-8.21M |
|
$-8.21M |
|
$-8.21M |
|
$-8.21M |
|
$-8.23M |
|
$-8.23M |
|
0.56M |
|
0.56M |
|
$-14.58 |
|
$-14.58 |
|
| Balance Sheet Financials | |
$14.52M |
|
-- |
|
$0.80M |
|
$15.31M |
|
$9.43M |
|
-- |
|
|
Long-Term Liabilities |
$0.50M |
$9.93M |
|
$5.39M |
|
$5.39M |
|
$5.39M |
|
0.56M |
|
| Cash Flow Statement Financials | |
$-26.87M |
|
-- |
|
$-1.21M |
|
$38.79M |
|
$10.70M |
|
$-28.08M |
|
$0.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.54 |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-152.47% |
|
-152.47% |
|
-53.63% |
|
-152.47% |
|
$9.57 |
|
$-47.73 |
|
$-47.73 |
|